[go: up one dir, main page]

AU2002359792A1 - Methods and compositions for the inhibition of viral release - Google Patents

Methods and compositions for the inhibition of viral release

Info

Publication number
AU2002359792A1
AU2002359792A1 AU2002359792A AU2002359792A AU2002359792A1 AU 2002359792 A1 AU2002359792 A1 AU 2002359792A1 AU 2002359792 A AU2002359792 A AU 2002359792A AU 2002359792 A AU2002359792 A AU 2002359792A AU 2002359792 A1 AU2002359792 A1 AU 2002359792A1
Authority
AU
Australia
Prior art keywords
inhibition
compositions
methods
viral release
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359792A
Other versions
AU2002359792A8 (en
Inventor
Yuval Reiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteologics Inc
Original Assignee
Proteologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteologics Inc filed Critical Proteologics Inc
Publication of AU2002359792A1 publication Critical patent/AU2002359792A1/en
Publication of AU2002359792A8 publication Critical patent/AU2002359792A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002359792A 2001-12-18 2002-12-18 Methods and compositions for the inhibition of viral release Abandoned AU2002359792A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34156801P 2001-12-18 2001-12-18
US60/341,568 2001-12-18
US36264902P 2002-03-09 2002-03-09
US60/362,649 2002-03-09
PCT/US2002/041028 WO2003051835A2 (en) 2001-12-18 2002-12-18 Methods and compositions for the inhibition of viral release

Publications (2)

Publication Number Publication Date
AU2002359792A1 true AU2002359792A1 (en) 2003-06-30
AU2002359792A8 AU2002359792A8 (en) 2003-06-30

Family

ID=26992569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359792A Abandoned AU2002359792A1 (en) 2001-12-18 2002-12-18 Methods and compositions for the inhibition of viral release

Country Status (2)

Country Link
AU (1) AU2002359792A1 (en)
WO (1) WO2003051835A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002327531A1 (en) 2001-08-22 2003-03-10 Myriad Genetics, Inc Therapeutic compositions and methods for treating viral infection
US8506967B2 (en) 2003-07-11 2013-08-13 Novavax, Inc. Functional influenza virus like particles (VLPs)
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
US8992939B2 (en) 2003-07-11 2015-03-31 Novavax, Inc. Highly efficient influenza matrix (M1) proteins
US8080255B2 (en) 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
EP3126005A4 (en) 2014-03-31 2017-11-29 The Trustees Of The University Of Pennsylvania Novel antiviral compounds and methods using same
US11260090B2 (en) 2016-03-08 2022-03-01 University Of Vermont And State Agricultural College Modified arenavirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
US5559209A (en) * 1993-02-18 1996-09-24 The General Hospital Corporation Regulator regions of G proteins
JPH08151396A (en) * 1994-11-28 1996-06-11 Teijin Ltd Hla-binding oligopeptide and immunomodulating agent containing the compound
US7202329B2 (en) * 2001-03-14 2007-04-10 Myriad Genetics, Inc. Tsg101-GAGp6 interaction and use thereof

Also Published As

Publication number Publication date
AU2002359792A8 (en) 2003-06-30
WO2003051835A2 (en) 2003-06-26
WO2003051835A3 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
AU2002300377A1 (en) Compositions for controlled release
AU2002357119A1 (en) Mitocidal compositions and methods
AU2003277103A1 (en) Creamer compositions and methods of making and using the same
AU6111000A (en) Inhibitors of viral helcase
AU2002307448A1 (en) Methods and compositions for the modulation of biofilm formation
AU2002309100A1 (en) Compositions and methods for the modulation of viral maturation
AU2002351388A1 (en) Methods and compositions for controlled release of drugs
AU2002215333A1 (en) Compositions for release of radiosensitizers, and methods of making and using the same
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2002359792A1 (en) Methods and compositions for the inhibition of viral release
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2002337843A1 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
AU2001292947A1 (en) Methods for inhibition of viral infection
AU2002366809A1 (en) Syn3 compositions and methods
AU2002365136A1 (en) Compositions and methods for controlled release
AU2002364911A1 (en) Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use
AU2002355432A1 (en) Kavalactone compositions and methods of use
AU2002350181A1 (en) Compositions and methods for viral delivery
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002360614A1 (en) Methods of inhibiting fertility
AU2001231983A1 (en) Delayed release of fluids
WO2003020115A9 (en) Methods and compositions for the detection of cancer
HK1067848A (en) Compositions and methods for controlled release
HK1086009A (en) Compositions and methods for viral inhibition
AU2002321556A1 (en) Inhibition of replication factor c

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase